MedPath

Podocytes derived from induced pluripotent stem cells as biomarker of disease-causing mutations

Recruiting
Conditions
collagen type IV nephropathy
hereditary nephritis
10029149
Registration Number
NL-OMON49859
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

1. Patients
* Established diagnosis of collagen IV nephropathy with disease-causing Col4
mutation.
2. Disease controls:
* diagnosis of focal segmental glomerulosclerosis (FSGS) with no evidence of
underlying genetic mutations.
3. Healthy controls:
* no signs of kidney disease, negative family history of kidney diseases (i.e.
proteinuria or hematuria with no proven cause).

Exclusion Criteria

* Unspecified kidney injury;
* Not able to provide informed consent.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Abnormal function of podocytes from patients with proven disease causing<br /><br>mutations compared to disease and healthy controls. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath